CNTA

Centessa Pharmaceuticals plc American Depositary Shares (CNTA)

About Centessa Pharmaceuticals plc American Depositary Shares (CNTA)

Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.

Details

Daily high

$16.78

Daily low

$15.84

Price at open

$15.97

52 Week High

$17.59

52 Week Low

$5.58

Market cap

1.9B

Dividend yield

0.00%

Volume

242,145

Avg. volume

552,956

P/E ratio

-10.69

Centessa Pharmaceuticals plc American Depositary Shares News